Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02511522 · OUTCOME

Proportion of Patients Alive at Day 90.

Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases · Source last updated 2024-10-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
percentage of alive at 90 days
Interval / dispersion
95% Confidence Interval
Time frame
90 days

What was measured

Estimated by Kaplan-Meier method for overall survival defined as time from randomization to death from any cause.

Analysis population: All patients randomized

Groups in this outcome

Radiotherapy Combined With Best Supportive Care

Patients receive a radiation therapy with the use of 8 Gy in one fraction to the whole (or near-whole) liver together with the best supportive care.

Best Supportive Care Alone

Patients receive only the best supportive care.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Radiotherapy Combined With Best Supportive Care33
Best Supportive Care Alone33

Reported measurements

Source class 1
Values in percentage of alive at 90 days · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Radiotherapy Combined With Best Supportive Care51.18Not reported33.1266.63Not reported
Best Supportive Care Alone32.99Not reported17.4649.42Not reported

Source statistical analyses

Group order, estimate direction, methods and comments are retained. No treatment ranking is inferred.

  1. group Ids
    1. OG000
    2. OG001
    non Inferiority Type
    SUPERIORITY
    p Value
    0.068
    statistical Comment
    Stratified Log Rank test adjusting for the stratification factor (Hepatocellular carcinoma versus liver metastases)
    statistical Method
    Log Rank
Complete source fields
analyses
  1. group Ids
    1. OG000
    2. OG001
    non Inferiority Type
    SUPERIORITY
    p Value
    0.068
    statistical Comment
    Stratified Log Rank test adjusting for the stratification factor (Hepatocellular carcinoma versus liver metastases)
    statistical Method
    Log Rank
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        33.12
        upper Limit
        66.63
        value
        51.18
      2. group Id
        OG001
        lower Limit
        17.46
        upper Limit
        49.42
        value
        32.99
denoms
  1. counts
    1. group Id
      OG000
      value
      33
    2. group Id
      OG001
      value
      33
    units
    Participants
description
Estimated by Kaplan-Meier method for overall survival defined as time from randomization to death from any cause.
dispersion Type
95% Confidence Interval
groups
  1. description
    Patients receive a radiation therapy with the use of 8 Gy in one fraction to the whole (or near-whole) liver together with the best supportive care.
    id
    OG000
    title
    Radiotherapy Combined With Best Supportive Care
  2. description
    Patients receive only the best supportive care.
    id
    OG001
    title
    Best Supportive Care Alone
param Type
NUMBER
population Description
All patients randomized
reporting Status
POSTED
time Frame
90 days
title
Proportion of Patients Alive at Day 90.
type
SECONDARY
unit Of Measure
percentage of alive at 90 days

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice